These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19442244)

  • 1. Functions of p53 in metabolism and invasion.
    Vousden KH
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):511-7. PubMed ID: 19442244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 mutation "gradient effect" and its clinical implications.
    Zambetti GP
    J Cell Physiol; 2007 Nov; 213(2):370-3. PubMed ID: 17671971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical simulation of p53-Mdm2 protein biological system regulation.
    Voropaeva OF; Shokin YI; Nepomnyashchikh LM; Senchukova SR
    Bull Exp Biol Med; 2014 Aug; 157(4):535-8. PubMed ID: 25110100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2-p53 pathway in hepatocellular carcinoma.
    Meng X; Franklin DA; Dong J; Zhang Y
    Cancer Res; 2014 Dec; 74(24):7161-7. PubMed ID: 25477334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of MDM2 oncogene and its impact on human cancers.
    Zhao Y; Yu H; Hu W
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):180-9. PubMed ID: 24389645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shaping genetic alterations in human cancer: the p53 mutation paradigm.
    Soussi T; Wiman KG
    Cancer Cell; 2007 Oct; 12(4):303-12. PubMed ID: 17936556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.
    Manfredi JJ
    Genes Dev; 2010 Aug; 24(15):1580-9. PubMed ID: 20679392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fortifying p53 - beyond Mdm2 inhibitors.
    Sriraman A; Li Y; Dobbelstein M
    Aging (Albany NY); 2016 Sep; 8(9):1836-1837. PubMed ID: 27688014
    [No Abstract]   [Full Text] [Related]  

  • 13. Mdm2-mediated ubiquitylation: p53 and beyond.
    Marine JC; Lozano G
    Cell Death Differ; 2010 Jan; 17(1):93-102. PubMed ID: 19498444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deconstruction of p53 functions and regulation.
    Haupt Y; Robles AI; Prives C; Rotter V
    Oncogene; 2002 Nov; 21(54):8223-31. PubMed ID: 12447685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Enigma of p53.
    Lozano G
    Cold Spring Harb Symp Quant Biol; 2016; 81():37-40. PubMed ID: 27932563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NEGATIVE REGULATORS OF TUMOR SUPPRESSOR P53 IN THE CONTEXT OF ANTICANCER THERAPY].
    Shuvalov OY; Fedorova OA; Petukhov AV; Daks AA; Vasilieva EA; Grigorieva TA; Ivanov GS; Barlev NA
    Tsitologiia; 2015; 57(12):847-54. PubMed ID: 26995961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of a SNiP of the MDM2 gene to modulate the p53 pathway and the predisposition to cancer].
    Larsen CJ
    Bull Cancer; 2011 Jan; 98(1):10. PubMed ID: 21591298
    [No Abstract]   [Full Text] [Related]  

  • 18. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
    Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
    Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.